Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Remdesivir for the treatment of COVID-19
Kelly Ansems, Felicitas Grundeis, Karolina Dahms, et al.
Cochrane library (2021) Vol. 2021, Iss. 8
Open Access | Times Cited: 197

Showing 26-50 of 197 citing articles:

Molecular docking and dynamics simulations reveal the potential of anti-HCV drugs to inhibit COVID-19 main protease
Ahmed A. Al‐Karmalawy, Radwan Alnajjar, Mohammed A. Dahab, et al.
Pharmaceutical Sciences (2021)
Open Access | Times Cited: 49
Systematic review on role of structure based drug design (SBDD) in the identification of anti-viral leads against SARS-Cov-2
Nilesh Gajanan Bajad, Rayala Swetha, Gopichand Gutti, et al.
Current Research in Pharmacology and Drug Discovery (2021) Vol. 2, pp. 100026-100026
Open Access | Times Cited: 48
Long-Term Health Symptoms and Sequelae Following SARS-CoV-2 Infection: An Evidence Map
Juan Víctor Ariel Franco, Luis Garegnani, Gisela Oltra, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 16, pp. 9915-9915
Open Access | Times Cited: 36
COVID-19 and the promise of small molecule therapeutics: Are there lessons to be learnt?
Wei Shen Ho, Ruirui Zhang, Yeong Lan Tan, et al.
Pharmacological Research (2022) Vol. 179, pp. 106201-106201
Open Access | Times Cited: 30
Remdesivir for the treatment of patients hospitalized with COVID-19 receiving supplemental oxygen: a targeted literature review and meta-analysis
Rachel Beckerman, Andrea Gori, Sushanth Jeyakumar, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 30
Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial
Erica Matino, Elena Tavella, Manuela Rizzi, et al.
Nutrients (2023) Vol. 15, Iss. 5, pp. 1285-1285
Open Access | Times Cited: 19
The efficacy and safety of remdesivir alone and in combination with other drugs for the treatment of COVID-19: a systematic review and meta-analysis
Chuizhe Chen, Junde Fang, Shu Chen, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 17
Remdesivir versus ritonavir/lopinavir in COVID-19 patients
Antonio Vitiello, Francesco Ferrara
Irish Journal of Medical Science (1971 -) (2020) Vol. 190, Iss. 3, pp. 1249-1250
Open Access | Times Cited: 42
PREVAIL IV: A Randomized, Double-Blind, 2-Phase, Phase 2 Trial of Remdesivir vs Placebo for Reduction of Ebola Virus RNA in the Semen of Male Survivors
Elizabeth S. Higgs, Dehkontee Gayedyu-Dennis, William A. Fischer, et al.
Clinical Infectious Diseases (2021) Vol. 73, Iss. 10, pp. 1849-1856
Open Access | Times Cited: 37
Treatments for COVID-19: Lessons from 2020 and new therapeutic options
Fanny Salasc, Thomas Lahlali, Emilie Laurent, et al.
Current Opinion in Pharmacology (2021) Vol. 62, pp. 43-59
Open Access | Times Cited: 34
Remdesivir for pregnancy: A systematic review of antiviral therapy for COVID-19
David Setyo Budi, Nando Reza Pratama, Ifan Ali Wafa, et al.
Heliyon (2022) Vol. 8, Iss. 1, pp. e08835-e08835
Open Access | Times Cited: 25
From standard systematic reviews to living systematic reviews
Claudia Breuer, Jörg J. Meerpohl, Waldemar Siemens
Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen (2023) Vol. 176, pp. 76-81
Open Access | Times Cited: 11
Use and effectiveness of remdesivir for the treatment of patients with covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS): a multicentre cohort study
Lisa Pilgram, Katharina S. Appel, Maria Madeleine Ruethrich, et al.
Infection (2023) Vol. 51, Iss. 4, pp. 1033-1049
Open Access | Times Cited: 11
Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2
Francisco Javier Candel, Pablo Barreiro, Miguel Salavert, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1449-1449
Open Access | Times Cited: 11
A computational approach to aid clinicians in selecting anti-viral drugs for COVID-19 trials
Aanchal Mongia, Sanjay Saha, Émilie Chouzenoux, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 26
Recommendations on the in-hospital treatment of patients with COVID-19
Stefan Kluge, Jakob J Malin, Falk Fichtner, et al.
Deutsches Ärzteblatt international (2021)
Open Access | Times Cited: 25
Potential SARS-CoV-2 3CLpro inhibitors from chromene, flavonoid and hydroxamic acid compound based on FRET assay, docking and pharmacophore studies
Maywan Hariono, Pandu Hariyono, Rini Dwiastuti, et al.
Results in Chemistry (2021) Vol. 3, pp. 100195-100195
Open Access | Times Cited: 24
Baricitinib combination therapy: a narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection
Mostafa Akbarzadeh-Khiavi, Mitra Torabi, Leila Rahbarnia, et al.
Infection (2021) Vol. 50, Iss. 2, pp. 295-308
Open Access | Times Cited: 24
Use of remdesivir in patients with COVID-19: a systematic review and meta-analysis
Suzana Érico Tanni, Antônio Silvinato, Idevaldo Floriano, et al.
Jornal Brasileiro de Pneumologia (2022), pp. e20210393-e20210393
Open Access | Times Cited: 19
Omicron-included mutation-induced changes in epitopes of SARS-CoV-2 spike protein and effectiveness assessments of current antibodies
Guo Du, Huaichuan Duan, Yan Cheng, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 18
COVID-19 infection: from stress-related cortisol levels to adrenal glands infarction
M Popescu, Dana Terzea, Mara Carşote, et al.
Romanian Journal of Morphology and Embryology (2022) Vol. 63, Iss. 1, pp. 39-48
Open Access | Times Cited: 18
Mapping Scientific Productivity Trends and Hotspots in Remdesivir Research Publications: A Bibliometric Study from 2016 to 2021
Ropo Ebenezer Ogunsakin, Oluwakemi Ebenezer, Maryam Amra Jordaan, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 14, pp. 8845-8845
Open Access | Times Cited: 17
An interpreter ranking index-based MCDM technique for COVID-19 treatments under a bipolar fuzzy environment
Totan Garai, Harish Garg
Results in Control and Optimization (2023) Vol. 12, pp. 100242-100242
Open Access | Times Cited: 10
Antiplatelet agents for the treatment of adults with COVID-19
Anna-Lena Fischer, Sarah Messer, Rachel Riera, et al.
Cochrane library (2023) Vol. 2023, Iss. 7
Open Access | Times Cited: 10
Antivirotics based on defective interfering particles: emerging concepts and challenges
S. V. Maryanchik, S. E. Borovikova, Anna O. Ivanova, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access

Scroll to top